Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05636800 · ClinicalTrials.gov registry record · NA
Microwave Treatment for Actinic Keratosis
A NA study of Keratosis, Actinic, sponsored by Blackwell Device Consulting.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 2
- Study locations
NCT05636800 is a NA study of Keratosis, Actinic that is active but no longer recruiting, run by Blackwell Device Consulting. The registered enrollment target is 60 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT05636800, a NA study of Keratosis, Actinic, is active but no longer recruiting, sponsored by Blackwell Device Consulting.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a randomized, controlled, multi-center trial in subjects diagnosed with Actinic Keratosis (AK) where each subject serves as their own control. The trial will be conducted at 2 sites, one in Germany and one in the United States. Approximately 60 subjects will be randomized to ensure 51 subjects complete the study.
Conditions Studied
Interventions
- DEVICE Swift System
Study Locations (2)
Florida
- Miami Dermatology and Laser Institute - Miami
Other
- Centroderm GmbH - Wuppertal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-01-18 |
| Est. Completion | 2024-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05636800
The ClinicalTrials.gov registry entry for NCT05636800 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Blackwell Device Consulting, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Keratosis, Actinic appearing as the primary indexed condition, and to 1 intervention - of which Swift System is the first listed.
NCT05636800 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Other.
Frequently Asked Questions
What is clinical trial NCT05636800 about?
NCT05636800 is a clinical study titled "Microwave Treatment for Actinic Keratosis". This is a randomized, controlled, multi-center trial in subjects diagnosed with Actinic Keratosis (AK) where each subject serves as their own control. The trial will be conducted at 2 sites, one in Germany and one in the United States. Approximately 60 subjects will be randomized to ensure 51 subjec...
What is the current status of trial NCT05636800?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-01-18. Estimated completion is 2024-11-01.
What conditions does trial NCT05636800 study?
This clinical trial studies the following conditions: Keratosis, Actinic.
What interventions are being tested in trial NCT05636800?
The interventions under investigation include: Swift System (DEVICE).
Who is sponsoring clinical trial NCT05636800?
This trial is sponsored by Blackwell Device Consulting, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05636800 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Keratosis, Actinic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.